Investigation of postoperative adjuvant chemotherapy for locally advanced transitional cell carcinoma

M. Saegusa, Y. Nakayama, T. Ichikawa, Daisuke Yamada, K. Aramaki

Research output: Contribution to journalArticle

Abstract

From April 1985 to March 1997, 48 patients with locally advanced transitional cell carcinoma of the bladder or upper urinary tract (≥pT3 or ≥pN1 or pR1 or vascular involvement) underwent curative surgery (total cystectomy or total nephroureterectomy) at our hospital. Of the 48 patients, 14 received combination chemotherapy as postoperative adjuvant therapy, while the remaining 34 had no such adjuvant combination chemotherapy. The adjuvant chemotherapy group comprised 11 males and 3 females, and the median age was 59.5 (range: 34 to 76) years old. The non-chemotherapy group comprised 26 males and 8 females, and the median age was 72.0 (range: 41 to 83) years old. The disease-specific survival rate by the Kaplan-Meier method between the adjuvant chemotherapy group and the non-chemotherapy group was evaluated statistically in terms of the logrank test. We evaluated the survival rate in all cases (48 cases), pT3 or greater cases (38 cases), cases aged 75 years or younger (35 cases), bladder cancer cases (19 cases), upper urinary tract cancer cases (29 cases), cases with vascular involvement (37 cases), and cases containing G3 (27 cases). There were no significant differences in survival rates between the two groups.

Original languageEnglish
Pages (from-to)643-646
Number of pages4
JournalNishinihon Journal of Urology
Volume62
Issue number12
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Transitional Cell Carcinoma
Adjuvant Chemotherapy
Survival Rate
Combination Drug Therapy
Blood Vessels
Urologic Neoplasms
Cystectomy
Urinary Tract
Urinary Bladder Neoplasms
Urinary Bladder
Therapeutics

Keywords

  • Adjuvant chemotherapy
  • Transitional cell carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Investigation of postoperative adjuvant chemotherapy for locally advanced transitional cell carcinoma. / Saegusa, M.; Nakayama, Y.; Ichikawa, T.; Yamada, Daisuke; Aramaki, K.

In: Nishinihon Journal of Urology, Vol. 62, No. 12, 2000, p. 643-646.

Research output: Contribution to journalArticle

Saegusa, M. ; Nakayama, Y. ; Ichikawa, T. ; Yamada, Daisuke ; Aramaki, K. / Investigation of postoperative adjuvant chemotherapy for locally advanced transitional cell carcinoma. In: Nishinihon Journal of Urology. 2000 ; Vol. 62, No. 12. pp. 643-646.
@article{01a412a3fdaa4164896ad5d3a4a19563,
title = "Investigation of postoperative adjuvant chemotherapy for locally advanced transitional cell carcinoma",
abstract = "From April 1985 to March 1997, 48 patients with locally advanced transitional cell carcinoma of the bladder or upper urinary tract (≥pT3 or ≥pN1 or pR1 or vascular involvement) underwent curative surgery (total cystectomy or total nephroureterectomy) at our hospital. Of the 48 patients, 14 received combination chemotherapy as postoperative adjuvant therapy, while the remaining 34 had no such adjuvant combination chemotherapy. The adjuvant chemotherapy group comprised 11 males and 3 females, and the median age was 59.5 (range: 34 to 76) years old. The non-chemotherapy group comprised 26 males and 8 females, and the median age was 72.0 (range: 41 to 83) years old. The disease-specific survival rate by the Kaplan-Meier method between the adjuvant chemotherapy group and the non-chemotherapy group was evaluated statistically in terms of the logrank test. We evaluated the survival rate in all cases (48 cases), pT3 or greater cases (38 cases), cases aged 75 years or younger (35 cases), bladder cancer cases (19 cases), upper urinary tract cancer cases (29 cases), cases with vascular involvement (37 cases), and cases containing G3 (27 cases). There were no significant differences in survival rates between the two groups.",
keywords = "Adjuvant chemotherapy, Transitional cell carcinoma",
author = "M. Saegusa and Y. Nakayama and T. Ichikawa and Daisuke Yamada and K. Aramaki",
year = "2000",
language = "English",
volume = "62",
pages = "643--646",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "12",

}

TY - JOUR

T1 - Investigation of postoperative adjuvant chemotherapy for locally advanced transitional cell carcinoma

AU - Saegusa, M.

AU - Nakayama, Y.

AU - Ichikawa, T.

AU - Yamada, Daisuke

AU - Aramaki, K.

PY - 2000

Y1 - 2000

N2 - From April 1985 to March 1997, 48 patients with locally advanced transitional cell carcinoma of the bladder or upper urinary tract (≥pT3 or ≥pN1 or pR1 or vascular involvement) underwent curative surgery (total cystectomy or total nephroureterectomy) at our hospital. Of the 48 patients, 14 received combination chemotherapy as postoperative adjuvant therapy, while the remaining 34 had no such adjuvant combination chemotherapy. The adjuvant chemotherapy group comprised 11 males and 3 females, and the median age was 59.5 (range: 34 to 76) years old. The non-chemotherapy group comprised 26 males and 8 females, and the median age was 72.0 (range: 41 to 83) years old. The disease-specific survival rate by the Kaplan-Meier method between the adjuvant chemotherapy group and the non-chemotherapy group was evaluated statistically in terms of the logrank test. We evaluated the survival rate in all cases (48 cases), pT3 or greater cases (38 cases), cases aged 75 years or younger (35 cases), bladder cancer cases (19 cases), upper urinary tract cancer cases (29 cases), cases with vascular involvement (37 cases), and cases containing G3 (27 cases). There were no significant differences in survival rates between the two groups.

AB - From April 1985 to March 1997, 48 patients with locally advanced transitional cell carcinoma of the bladder or upper urinary tract (≥pT3 or ≥pN1 or pR1 or vascular involvement) underwent curative surgery (total cystectomy or total nephroureterectomy) at our hospital. Of the 48 patients, 14 received combination chemotherapy as postoperative adjuvant therapy, while the remaining 34 had no such adjuvant combination chemotherapy. The adjuvant chemotherapy group comprised 11 males and 3 females, and the median age was 59.5 (range: 34 to 76) years old. The non-chemotherapy group comprised 26 males and 8 females, and the median age was 72.0 (range: 41 to 83) years old. The disease-specific survival rate by the Kaplan-Meier method between the adjuvant chemotherapy group and the non-chemotherapy group was evaluated statistically in terms of the logrank test. We evaluated the survival rate in all cases (48 cases), pT3 or greater cases (38 cases), cases aged 75 years or younger (35 cases), bladder cancer cases (19 cases), upper urinary tract cancer cases (29 cases), cases with vascular involvement (37 cases), and cases containing G3 (27 cases). There were no significant differences in survival rates between the two groups.

KW - Adjuvant chemotherapy

KW - Transitional cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0034524571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034524571&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034524571

VL - 62

SP - 643

EP - 646

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 12

ER -